Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
Open | $6.180 |
Close | $6.150 |
Volume / Avg. | 783.453K / 1.292M |
Day Range | 5.860 - 6.410 |
52 Wk Range | 5.890 - 24.810 |
Market Cap | $377.535M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 14.37% |
Days to Cover | 7.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Replimune Group (NASDAQ: REPL) through any online brokerage.
Other companies in Replimune Group’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and PepGen (NASDAQ:PEPG).
The latest price target for Replimune Group (NASDAQ: REPL) was reported by Barclays on Wednesday, December 6, 2023. The analyst firm set a price target for 13.00 expecting REPL to rise to within 12 months (a possible 111.38% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Replimune Group (NASDAQ: REPL) is $6.15 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Replimune Group.
Replimune Group’s Q4 earnings are confirmed for Thursday, May 16, 2024.
There is no upcoming split for Replimune Group.
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.